5.4% Below Target

The consensus price target for CVS is $103.64, close to the current price of $98.32 (5.4% implied move). Based on 41 analyst estimates, the stock appears fairly valued near current levels.

CVS has a consensus rating of "Buy" based on 41 Wall Street analysts. The rating breakdown is predominantly bullish, with 35 Buy/Strong Buy ratings. The consensus 12-month price target of $103.64 implies 5.4% upside from current levels.

With a forward P/E of 13.2503x, CVS trades at a relatively low valuation. The consensus target of $103.64 implies 5.4% appreciation, suggesting the market may be pricing in risks.

The most bullish Wall Street analyst has a price target of $115 for CVS, while the most conservative target is $90. The consensus of $103.64 represents the median expectation. Our quantitative valuation model projects a bull case target of $328 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CVS is heavily covered by Wall Street, with 41 analysts providing price targets and ratings. Of these, 2 have Strong Buy ratings, 33 have Buy ratings, 6 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CVS stock forecast based on 41 Wall Street analysts shows a consensus price target of $103.64, with estimates ranging from $90 (bear case) to $115 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $249, with bear/bull scenarios of $157/$328.

Our quantitative valuation model calculates CVS's fair value at $249 (base case), with a bear case of $157 and bull case of $328. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.

CVS trades at a forward P/E ratio of 13.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 70.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

CVS appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $103.64 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CVS analyst price targets range from $90 to $115, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $103.64 consensus represents the middle ground. Our model's $157-$328 range provides an independent fundamental perspective.